Dava Stewart

A UK study aims to tackle poorly controlled asthma and misdiagnoses

At one year, nearly as many on monotherapy were in remission as on combo therapy.

Prolonged, repetitive hard work is a risk factor for RA, according to a new study.

Alone or combined with methotrexate, benefits continued through week 104.

Researchers evaluate risk of AID-defining and non-AIDS-defining cancers.

Researchers analyzed liver fibrosis levels in HIV, hepatitis B coinfection.

Laws prohibiting same-sex sexual behaviors are linked to implausibly low MSM estimates.

Researchers explore cytomegalovirus in patients with HIV.

The global gag rule could hurt progress made in fighting HIV.

Schizophrenia and rheumatoid arthritis appear to have a DNA level connection.

Treg and Breg cells can be very telling for rheumatoid arthritis treatment.

Arthro-haptic 3D printed prototypes give patients an emotional experience.

Patients who didn't respond to methotrexate may do well on baricitinib.

Drug combo deemed effective for one of the rarest hepatitis C genotypes in the United States.

Treatment deemed effective for patients with hepatitis C and less than one year life expectancy.

Dual infection with hepatitis B and C results in a competition.

Renal failure complicates hepatitis C treatment, but there's options.

Three patients with porphyria cutanea tarda benefited from hepatitis C treatment.

Simeprevir-based regimens helped 90% of patients with hepatitis C achieve SVR.

Hepatitis C replication is associated with neuroinflammatory conditions, which could lead to cognitive deficits.

Researchers address the controversial topic of B-cell infection by hepatitis C.

Researchers studying treatment-modifying covariates using network meta-regression analyses for stroke prevention in atrial fibrillation reported disappointing results.

3D treatment helped patients to attain SVR in less than 12 weeks.

Previous studies have shown that “the gut microbiota differs in composition and diversity during the first months of life in children who later do or do not have allergic disease," but researchers who focused on immunoglobulin A prevalence made a different finding.

Dutch researchers used radiolabeling to observe certolizumab in the body for the first time. Such studies could provide a greater understanding of how TNF inhibitors can be best used in the treatment of inflammatory conditions like arthritis.

The pros identified included the possibility of EMDs improving adherence, that the devices might help motivate patients through creating a sense of independence and accountability, and that the data generated could help in building a trusting relationship between clinician and patient.

Patients said that it can be difficult to identify opportunities to participate in research, and all groups agreed that a “language gap” exists between researchers and patients.

There are five different tumor necrosis factor (TNF) inhibitors available for the treatment of RA. Researchers say that despite showing similar efficacy, they differ in molecular structures and signaling disruption.

The FDA this week announced approval of Maci, “matrix-induced autologous chondrocyte implantation.” The treatment is intended for cartilage defects of the knee, which can eventually lead to osteoarthritis.

Using data from the Inner-City Asthma Consortium, researchers were able to identify the factors that contribute to more than half the variance in asthma severity, including allergic sensitization and, significantly, environmental tobacco smoke.